Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Rodrigues

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysisDavid A Palma, Suresh Senan, Cary Oberije, et al.
The Journal of Urology|January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
JAMA Oncology|May 15, 2023
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic CarcinomaStephen G Chun, Andreas Rimner, Arya Amini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerAndrew Warner, Max Dahele, Bo Hu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium SocietyHenry S Park, Andreas Rimner, Arya Amini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
Practical Radiation Oncology|June 10, 2017
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based GuidelineGregory M M Videtic, Jessica Donington, Meredith Giuliani, et al.
The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future DirectionsJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.
The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based ManagementJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysisDavid A Palma, Suresh Senan, Cary Oberije, et al.
The Journal of Urology|January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
JAMA Oncology|May 15, 2023
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic CarcinomaStephen G Chun, Andreas Rimner, Arya Amini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerAndrew Warner, Max Dahele, Bo Hu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium SocietyHenry S Park, Andreas Rimner, Arya Amini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
Practical Radiation Oncology|June 10, 2017
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based GuidelineGregory M M Videtic, Jessica Donington, Meredith Giuliani, et al.
The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future DirectionsJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.
The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based ManagementJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Pageof 19